New anticancer drugs linked to increased costs, life expectancySeptember 12, 2016Genitourinary CancerPractice ManagementLung CancerBreast CancerLymphoma & Plasma Cell Disorders
Large retrospective study challenges updated ASCO-CAP HER2 categorizationsSeptember 1, 2016Breast Cancer
ESR1 mutations found prognostic but not predictive in metastatic breast cancerAugust 8, 2016Breast Cancer
Clinical value of costly ER/PR testing of ductal carcinoma biopsies questionedJuly 27, 2016Breast Cancer
Anthracycline benefit for high-risk breast cancer confirmed in joint analysisJuly 27, 2016Breast Cancer
Overweight, obesity increase risk of cardiotoxicity from anthracyclinesJuly 25, 2016Breast CancerPatient & Survivor Care
Study shows faster increase in obesity prevalence among cancer survivorsJuly 25, 2016Breast CancerGastroenterologyPatient & Survivor CareGastrointestinal Cancer
New HER2-testing guidelines result in more women eligible for HER2-directed treatmentJuly 25, 2016Breast Cancer
New data shed light on impact of resecting the primary tumor in stage IV breast cancerJuly 20, 2016Breast Cancer
